Home/Filings/4/0001235802-20-000111
4//SEC Filing

Lightman James 4

Accession 0001235802-20-000111

CIK 0001492658other

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 4:44 PM ET

Size

6.0 KB

Accession

0001235802-20-000111

Insider Transaction Report

Form 4
Period: 2020-08-17
Lightman James
SVP, General Counsel & Secty
Transactions
  • Sale

    Ordinary Shares, par value EUR 0.03 per share

    2020-08-17$30.16/sh1,526$46,03097,999 total
Footnotes (3)
  • [F1]These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.1601 to $30.165, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
  • [F3]Includes 5,877 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 36,278 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.

Issuer

Wright Medical Group N.V.

CIK 0001492658

Entity typeother

Related Parties

1
  • filerCIK 0001317960

Filing Metadata

Form type
4
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 4:44 PM ET
Size
6.0 KB